Aehr Test Systems (AEHR)
Market Price (3/29/2026): $32.2 | Market Cap: $971.7 MilSector: Information Technology | Industry: Electronic Equipment & Instruments
Aehr Test Systems (AEHR)
Market Price (3/29/2026): $32.2Market Cap: $971.7 MilSector: Information TechnologyIndustry: Electronic Equipment & Instruments
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Megatrend and thematic driversMegatrends include Electric Vehicles & Autonomous Driving, Renewable Energy Transition, and Artificial Intelligence. Themes include EV Manufacturing, Show more. | Weak multi-year price returns3Y Excs Rtn is -73% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -12 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -23% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 15% | Expensive valuation multiplesP/SPrice/Sales ratio is 18x | |
| Stock price has recently run up significantly12M Rtn12 month market price return is 313% | ||
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.2%, Rev Chg QQuarterly Revenue Change % is -27% | ||
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 13% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -10%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -22% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.9% | ||
| High stock price volatilityVol 12M is 110% | ||
| Key risksAEHR key risks include [1] its heavy dependence on a single major customer in the Silicon Carbide/EV market and [2] the potential failure to convert strategic evaluations with new AI processor suppliers into high-volume production orders. |
| Megatrend and thematic driversMegatrends include Electric Vehicles & Autonomous Driving, Renewable Energy Transition, and Artificial Intelligence. Themes include EV Manufacturing, Show more. |
| Weak multi-year price returns3Y Excs Rtn is -73% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 15% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -12 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -23% |
| Expensive valuation multiplesP/SPrice/Sales ratio is 18x |
| Stock price has recently run up significantly12M Rtn12 month market price return is 313% |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.2%, Rev Chg QQuarterly Revenue Change % is -27% |
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 13% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -10%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -22% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.9% |
| High stock price volatilityVol 12M is 110% |
| Key risksAEHR key risks include [1] its heavy dependence on a single major customer in the Silicon Carbide/EV market and [2] the potential failure to convert strategic evaluations with new AI processor suppliers into high-volume production orders. |
Qualitative Assessment
AI Analysis | Feedback
1. Significant orders for AI processors and data center applications boosted investor confidence.
Aehr Test Systems received a $14 million order from its primary AI processor customer for fully automated FOX-XP Wafer-Level Burn-In Systems on February 26, 2026. This was preceded by an announcement on January 8, 2026, of over $5.5 million in Sonoma Ultra-High-Power System orders for testing and burning-in AI processors and data center interconnects. These substantial orders highlight strong demand for Aehr's specialized testing solutions within rapidly growing technology sectors.
2. Improved financial outlook driven by an earnings beat and reinstated revenue guidance.
On January 8, 2026, Aehr Test Systems reported its second-quarter fiscal 2026 results, with a non-GAAP net loss per diluted share of $(0.04), which surpassed analyst expectations of a $(0.08) loss. Concurrently, the company reinstated its financial guidance for the second half of fiscal year 2026, projecting revenue between $25 million and $30 million. This provided improved visibility into future performance and indicated a positive operational trajectory.
Show more
Stock Movement Drivers
Fundamental Drivers
The 40.2% change in AEHR stock from 11/30/2025 to 3/29/2026 was primarily driven by a 50.8% change in the company's P/S Multiple.| (LTM values as of) | 11302025 | 3292026 | Change |
|---|---|---|---|
| Stock Price ($) | 22.97 | 32.20 | 40.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 57 | 53 | -6.3% |
| P/S Multiple | 12.1 | 18.2 | 50.8% |
| Shares Outstanding (Mil) | 30 | 30 | -0.8% |
| Cumulative Contribution | 40.2% |
Market Drivers
11/30/2025 to 3/29/2026| Return | Correlation | |
|---|---|---|
| AEHR | 41.6% | |
| Market (SPY) | -5.3% | 58.6% |
| Sector (XLK) | -9.1% | 62.2% |
Fundamental Drivers
The 29.1% change in AEHR stock from 8/31/2025 to 3/29/2026 was primarily driven by a 44.6% change in the company's P/S Multiple.| (LTM values as of) | 8312025 | 3292026 | Change |
|---|---|---|---|
| Stock Price ($) | 24.95 | 32.20 | 29.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 59 | 53 | -9.7% |
| P/S Multiple | 12.6 | 18.2 | 44.6% |
| Shares Outstanding (Mil) | 30 | 30 | -1.2% |
| Cumulative Contribution | 29.1% |
Market Drivers
8/31/2025 to 3/29/2026| Return | Correlation | |
|---|---|---|
| AEHR | 30.3% | |
| Market (SPY) | 0.6% | 55.8% |
| Sector (XLK) | -0.7% | 56.7% |
Fundamental Drivers
The 234.0% change in AEHR stock from 2/28/2025 to 3/29/2026 was primarily driven by a 223.8% change in the company's P/S Multiple.| (LTM values as of) | 2282025 | 3292026 | Change |
|---|---|---|---|
| Stock Price ($) | 9.64 | 32.20 | 234.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 51 | 53 | 5.0% |
| P/S Multiple | 5.6 | 18.2 | 223.8% |
| Shares Outstanding (Mil) | 30 | 30 | -1.7% |
| Cumulative Contribution | 234.0% |
Market Drivers
2/28/2025 to 3/29/2026| Return | Correlation | |
|---|---|---|
| AEHR | 237.3% | |
| Market (SPY) | 9.8% | 49.1% |
| Sector (XLK) | 15.9% | 52.6% |
Fundamental Drivers
The -3.4% change in AEHR stock from 2/28/2023 to 3/29/2026 was primarily driven by a -12.8% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 2282023 | 3292026 | Change |
|---|---|---|---|
| Stock Price ($) | 33.35 | 32.20 | -3.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 61 | 53 | -12.8% |
| P/S Multiple | 15.1 | 18.2 | 21.1% |
| Shares Outstanding (Mil) | 28 | 30 | -8.6% |
| Cumulative Contribution | -3.4% |
Market Drivers
2/28/2023 to 3/29/2026| Return | Correlation | |
|---|---|---|
| AEHR | -2.5% | |
| Market (SPY) | 69.4% | 41.5% |
| Sector (XLK) | 94.5% | 41.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AEHR Return | 856% | -17% | 32% | -37% | 21% | 71% | 1266% |
| Peers Return | 41% | -43% | 53% | -7% | 79% | 15% | 135% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -5% | 72% |
Monthly Win Rates [3] | |||||||
| AEHR Win Rate | 58% | 50% | 42% | 33% | 50% | 67% | |
| Peers Win Rate | 65% | 33% | 60% | 45% | 53% | 53% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| AEHR Max Drawdown | -22% | -71% | -14% | -62% | -59% | 0% | |
| Peers Max Drawdown | -12% | -56% | -13% | -24% | -21% | -4% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -5% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ZBRA, MASS, AMAT, LRCX, KLAC. See AEHR Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/27/2026 (YTD)
How Low Can It Go
| Event | AEHR | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -73.0% | -25.4% |
| % Gain to Breakeven | 270.6% | 34.1% |
| Time to Breakeven | 145 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -57.3% | -33.9% |
| % Gain to Breakeven | 134.2% | 51.3% |
| Time to Breakeven | 314 days | 148 days |
| 2018 Correction | ||
| % Loss | -80.4% | -19.8% |
| % Gain to Breakeven | 410.4% | 24.7% |
| Time to Breakeven | 914 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -92.6% | -56.8% |
| % Gain to Breakeven | 1246.1% | 131.3% |
| Time to Breakeven | 4,462 days | 1,480 days |
Compare to ZBRA, MASS, AMAT, LRCX, KLAC
In The Past
Aehr Test Systems's stock fell -73.0% during the 2022 Inflation Shock from a high on 11/5/2021. A -73.0% loss requires a 270.6% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Aehr Test Systems (AEHR)
AI Analysis | Feedback
Here are 1-3 brief analogies for Aehr Test Systems (AEHR):
- AEHR is like the ASML for chip reliability and testing. (ASML makes crucial equipment for manufacturing chips; AEHR makes crucial equipment for testing and ensuring their reliability.)
- Think of AEHR as the Siemens Healthineers for the semiconductor industry, providing advanced diagnostic equipment for chips. (Siemens Healthineers makes advanced medical diagnostic equipment.)
- It's like the specialized Underwriters Laboratories (UL) for microchips, providing the essential equipment to test and verify their quality and reliability. (UL is known for product safety and quality testing across various industries.)
AI Analysis | Feedback
- Advanced Burn-in and Test System (ABTS) family: Systems designed for test during burn-in of packaged complex and high-power logic devices.
- FOX systems: Parallel test and burn-in systems for simultaneously contacting devices on wafers or panels.
- WaferPak Contactor: A full-wafer probe card used specifically for testing wafers within FOX systems.
- DiePak Carrier: A reusable temporary package that facilitates test and burn-in for singulated bare die or small multi-IC modules.
- Test Fixtures: Components that physically hold and electrically connect devices to the test system during burn-in and test processes.
- WaferPak Aligner: Equipment that automatically aligns customer wafers to the WaferPak Contactor for testing.
- DiePak Loader: Equipment that automatically loads customer modules into the DiePak Carrier for test and burn-in.
- Customer Service and Support Programs: Comprehensive post-sale support including system installation, repair, applications engineering assistance, spare parts, training, and documentation.
AI Analysis | Feedback
Based on the provided background information, Aehr Test Systems (AEHR) primarily sells its products to other companies in the semiconductor and electronics industries. The description does not explicitly name specific major customer companies. However, it identifies the following categories of customers that Aehr Test Systems markets and sells its products to:- Semiconductor manufacturers
- Semiconductor contract assemblers
- Electronics manufacturers
- Burn-in and test service companies
AI Analysis | Feedback
nullAI Analysis | Feedback
Gayn Erickson, President and Chief Executive Officer
Gayn Erickson joined Aehr Test Systems as President and Chief Executive Officer in January 2012. He has over 35 years of executive and general management, operations, marketing, sales, and R&D program management experience in the semiconductor test industry. Prior to joining Aehr, Mr. Erickson served as Corporate Officer and Senior Vice President & General Manager of Verigy's memory test business, which was subsequently acquired by Advantest Japan. Before Verigy, he was Vice President of Marketing and Sales for Agilent Technologies' Semiconductor Memory Test products. He began his career in semiconductor test with Hewlett-Packard's Automated Test Group in the late 1980s.
Chris P. Siu, Executive Vice President, Finance, Chief Financial Officer and Principal Accounting Officer
Chris P. Siu was appointed Executive Vice President of Finance and Chief Financial Officer of Aehr Test Systems in June 2023. He brings over 27 years of finance and accounting experience in the semiconductor, medical equipment, and public accounting industries. Prior to Aehr, he spent four years in senior finance executive roles at Ultra Clean Technologies, a publicly traded company serving the semiconductor equipment industry, including Senior Vice President of Finance, Corporate Treasurer, and Chief Accounting Officer. Mr. Siu also held senior management positions at PDF Solutions and GlobalFoundries, where he served for eight years, including four years as Corporate Controller leading all global accounting functions. His experience also includes roles as Chief Accounting Officer and Director of Finance at Trident Microsystems and various senior finance management positions at Varian Medical Systems. He started his career in public accounting with EY and Deloitte, where he reached the position of Audit Manager.
Adil Engineer, Chief Operating Officer
Adil Engineer joined Aehr Test Systems as Chief Operating Officer in April 2022. He has over 20 years of experience in operations and supply chain within the semiconductor and medical equipment sectors. Before joining Aehr, Mr. Engineer was the Head of Operations at Tecan, a Swiss company specializing in medical test and diagnostic tools, where he managed operations for their primary U.S. manufacturing site. His career began at KLA-Tencor, a semiconductor equipment company, where he worked for 11 years. He also held positions of increasing responsibility in manufacturing, manufacturing engineering, new product introduction, and supply chain at Coherent and Kateeva.
Donald P. Richmond II, Chief Technology Officer
Donald P. Richmond II has served as Chief Technology Officer for Aehr Test Systems. He initially joined the company in 1998 as a Senior Electrical Engineer for Aehr's Wafer Level Test and Burn-in solutions and was elected Vice President of Engineering in March 2018. Prior to his tenure at Aehr, Mr. Richmond co-founded ChipScale Inc. / Micro SMT Inc., where he was a member of the Board of Directors and served as Vice President of Operations. Earlier in his career, he was president of TEAM Holdings LTD. / TEAM International LTD., a semiconductor packaging subcontract company.
Vernon Rogers, Executive Vice President, Sales and Marketing
Vernon Rogers was appointed Executive Vice President of Sales and Marketing at Aehr Test Systems in October 2018. He possesses over 22 years of senior executive experience in sales, marketing, and operations management, having successfully built multi-channel sales distribution and support organizations for both public and start-up technology companies in the semiconductor and system-level test space. Before joining Aehr, Mr. Rogers served as head of sales and marketing at Global Equipment Services (GES) prior to its acquisition by Kimball Electronics. His career includes a focus on nanoscale inspection, manufacturing, and test technologies at companies such as LitePoint (acquired by Teradyne), Credence Systems Corporation (acquired by Xcerra), NPTest (acquired by Credence Systems), and Schlumberger Automated Test Equipment.
AI Analysis | Feedback
Aehr Test Systems (AEHR) faces several key risks inherent to its position in the specialized semiconductor equipment market. The most significant risks include high customer concentration, dependence on the adoption rates of specific semiconductor technologies and end-markets, and intense competition coupled with the rapid pace of technological change.Key Risks to Aehr Test Systems (AEHR)
- Customer Concentration: A substantial portion of Aehr Test Systems' revenue is derived from a very limited number of customers. In a recent quarter, approximately 88% of its revenue came from a single customer, and 79% in fiscal year 2023. This high level of customer concentration means that a significant reduction in orders, a change in technology preferences, or financial difficulties experienced by this key customer could have a material adverse effect on Aehr's financial performance and stock price. While the company has indicated efforts to diversify its customer base, this remains a dominant risk.
- Dependency on Silicon Carbide (SiC)/Gallium Nitride (GaN) Market Adoption and EV Adoption Timing: Aehr's growth trajectory is heavily influenced by the adoption of silicon carbide (SiC) and gallium nitride (GaN) power semiconductors, particularly in the electric vehicle (EV) market. Uncertainties surrounding the rate of adoption for these advanced semiconductor materials or slower-than-anticipated growth in the EV market could directly impact the demand for Aehr's test and burn-in equipment. Furthermore, there is ongoing debate within the industry regarding the extent of burn-in testing required for SiC chips, which could affect future sales volumes even among existing customers.
- Intense Competition and Rapid Technological Obsolescence: The semiconductor equipment industry is highly competitive and characterized by rapid technological advancements. Aehr Test Systems faces competition from larger, more established automatic test equipment (ATE) suppliers who could introduce new products with superior performance or more aggressive pricing, potentially eroding Aehr's market share and profit margins. To remain competitive, Aehr must continually invest significant resources in research and development to innovate and enhance its product offerings. Failure to keep pace with evolving technological demands or to introduce next-generation solutions could lead to a decline in sales and loss of market acceptance for its products.
AI Analysis | Feedback
null
AI Analysis | Feedback
Aehr Test Systems (NASDAQ: AEHR) addresses several significant markets with its semiconductor test and burn-in equipment. The company's main products and services cater to the following addressable markets:
- Burn-in Tools for AI Processors: The total addressable market for burn-in tools used in AI processors is projected to range from $1.5 billion to $2.3 billion globally by 2030.
- Global Burn-In Test System for Semiconductor Market: This market was valued at $731 million in 2024 and is forecast to grow to $1.204 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period. Another estimate places the global market value at $756 million in 2024, with a projection to reach $1.448 billion by 2031 at a CAGR of 9.9%.
- U.S. Burn-In Test System for Semiconductor Market: The U.S. market for burn-in test systems for semiconductors was valued at $180.29 million in 2025 and is projected to grow to $337.03 million by 2033, with a CAGR of 8.18% from 2026 to 2033.
- Global Semiconductor Test Equipment Market: The overall global semiconductor test equipment market size was valued at $7.65 billion in 2025 and is projected to reach $14.38 billion by 2034, demonstrating a CAGR of 7.35%.
- Data Storage (Hard Disk Drive) Market: The hard disk market, which Aehr's systems address for quality and long-term reliability, is projected to grow from $62.4 billion in 2024 to over $100 billion by 2032 globally.
Aehr Test Systems' FOX family of test and burn-in systems, including WaferPak contactors and DiePak carriers, are utilized in these markets for various applications such as silicon carbide, gallium nitride power semiconductors, data storage devices, and silicon photonics integrated circuits.
AI Analysis | Feedback
Aehr Test Systems (AEHR) is anticipated to experience future revenue growth over the next 2-3 years, driven by several key factors in the semiconductor industry:
- Artificial Intelligence (AI) Processors and Data Center Infrastructure: Aehr Test Systems expects significant revenue growth from the increasing demand for testing and burn-in solutions for AI processors. The company has secured orders for its FOX-XP and Sonoma systems for both wafer-level and package-level burn-in of AI processors, including those used in hyperscale data centers and for AI optical I/O. Management foresees substantial growth from these initial AI customers, with expectations for expanded orders in fiscal years 2027 and 2028. Bookings related to AI processor testing are projected to be a major contributor to future revenue.
- Silicon Carbide (SiC) Semiconductors for Electric Vehicles (EVs) and Other Applications: While Aehr Test Systems has faced some near-term challenges and inventory-related headwinds in the silicon carbide market, particularly for automotive applications, it remains a significant long-term growth driver. The company's WaferPak Contactors and FOX systems are crucial for testing SiC power semiconductors in electric vehicles, as well as in solar and wind power applications. Aehr's management anticipates a strengthening of silicon carbide growth into fiscal year 2027, believing that most EV manufacturers will eventually adopt SiC-based technology.
- Gallium Nitride (GaN) Power Semiconductors: The increasing adoption of gallium nitride devices for applications such as data center power efficiency, automotive systems, and electrical infrastructure is expected to drive revenue growth for Aehr. The company is actively pursuing new engagements in this market, viewing it as a strategic expansion area that will create new opportunities and contribute to overall revenue.
- Silicon Photonics Integrated Circuits and Flash Memory Testing: Aehr Test Systems is observing growing demand for its FOX-XP systems for testing silicon photonics integrated circuits, specifically for AI optical I/O and data center interconnects. Additionally, there is rising interest in FOX-XP systems from NAND flash memory suppliers, presenting a potential for significant revenue if Aehr establishes customer relationships with companies expanding their memory production capacity.
AI Analysis | Feedback
Share Repurchases
- Aehr Test Systems has not engaged in significant open-market share repurchase programs as a capital allocation strategy in the last 3-5 years.
- The company repurchased shares primarily for tax withholdings on the vesting of restricted stock units, amounting to $0.784 million in fiscal 2025 and $1.596 million in fiscal 2024.
- Aehr did not repurchase any common stock in the open market during fiscal year 2024 due to the absence of a stock repurchase plan.
Share Issuance
- In February 2023, Aehr announced an At-The-Market (ATM) offering to sell up to $25 million of common stock for general corporate purposes, including increasing working capital, inventory, funding research and development, commercial activities, and capital expenditures.
- The company issued common stock under employee plans, generating proceeds of $1.409 million in fiscal 2025 and $1.807 million in fiscal 2024.
- Aehr Test Systems issued 552,355 shares of restricted common stock as part of the acquisition consideration for Incal Technology on August 1, 2024.
Inbound Investments
- Aehr Test Systems raised an undisclosed amount in a Post IPO funding round on February 6, 2022, with participation from investors including Herald Investment Management, Summit Partners, QVT Family Office, and Deutsche Bank.
- Vanguard Group Inc acquired 2,138,760 shares of Aehr Test Systems on September 30, 2024, at a price of $12.85 per share, representing a strategic investment.
Outbound Investments
- Aehr Test Systems completed the acquisition of Incal Technology, Inc. on August 1, 2024, for $21 million.
- The acquisition consideration for Incal Technology comprised $14 million in cash and 552,355 shares of Aehr stock.
- This acquisition expanded Aehr's product portfolio to include high-power packaged part reliability/burn-in test solutions, particularly for AI accelerators, GPUs, and high-performance computing processors.
Capital Expenditures
- Capital expenditures were $4.992 million in fiscal 2025 and $0.749 million in fiscal 2024.
- In the first quarter of fiscal 2026 (ended August 29, 2025), capital expenditures totaled $1.391 million, contributing to a total of $6.3 million spent on facility expansion.
- The primary focus of recent capital expenditures has been to support the consolidation and upgrade of its Fremont manufacturing facility and headquarters, and to expand capabilities for new product lines, particularly for AI processors.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to AEHR.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | BMI | Badger Meter | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02282026 | VRNS | Varonis Systems | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | ITRI | Itron | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | FSLR | First Solar | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | PEGA | Pegasystems | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 205.67 |
| Mkt Cap | 99.0 |
| Rev LTM | 9,070 |
| Op Inc LTM | 3,076 |
| FCF LTM | 2,604 |
| FCF 3Y Avg | 2,100 |
| CFO LTM | 2,842 |
| CFO 3Y Avg | 2,303 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 12.9% |
| Rev Chg 3Y Avg | 3.8% |
| Rev Chg Q | 8.9% |
| QoQ Delta Rev Chg LTM | 2.2% |
| Op Mgn LTM | 22.3% |
| Op Mgn 3Y Avg | 21.8% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 23.9% |
| CFO/Rev 3Y Avg | 21.3% |
| FCF/Rev LTM | 18.7% |
| FCF/Rev 3Y Avg | 17.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 99.0 |
| P/S | 11.1 |
| P/EBIT | 21.2 |
| P/E | 29.0 |
| P/CFO | 20.8 |
| Total Yield | 3.2% |
| Dividend Yield | 0.2% |
| FCF Yield 3Y Avg | 3.6% |
| D/E | 0.0 |
| Net D/E | -0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -10.2% |
| 3M Rtn | 15.1% |
| 6M Rtn | 20.8% |
| 12M Rtn | 123.8% |
| 3Y Rtn | 84.4% |
| 1M Excs Rtn | -5.5% |
| 3M Excs Rtn | 23.5% |
| 6M Excs Rtn | 23.4% |
| 12M Excs Rtn | 103.2% |
| 3Y Excs Rtn | 27.7% |
Price Behavior
| Market Price | $32.52 | |
| Market Cap ($ Bil) | 1.0 | |
| First Trading Date | 08/15/1997 | |
| Distance from 52W High | -26.1% | |
| 50 Days | 200 Days | |
| DMA Price | $33.23 | $24.84 |
| DMA Trend | up | up |
| Distance from DMA | -2.1% | 30.9% |
| 3M | 1YR | |
| Volatility | 126.7% | 110.0% |
| Downside Capture | 2.47 | 2.44 |
| Upside Capture | 848.82 | 444.17 |
| Correlation (SPY) | 59.4% | 47.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 7.44 | 5.42 | 5.27 | 4.54 | 2.58 | 2.49 |
| Up Beta | 8.06 | 7.89 | 7.62 | 4.54 | 2.57 | 2.34 |
| Down Beta | 11.38 | 4.86 | 4.07 | 3.07 | 1.42 | 1.51 |
| Up Capture | 1155% | 1166% | 1114% | 1424% | 2917% | 12491% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 12 | 25 | 33 | 62 | 124 | 345 |
| Down Capture | 305% | 207% | 308% | 300% | 164% | 113% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 9 | 16 | 28 | 62 | 125 | 403 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AEHR | |
|---|---|---|---|---|
| AEHR | 275.4% | 110.3% | 1.69 | - |
| Sector ETF (XLK) | 22.4% | 26.8% | 0.73 | 51.3% |
| Equity (SPY) | 14.5% | 18.9% | 0.59 | 47.9% |
| Gold (GLD) | 50.2% | 27.7% | 1.46 | 18.6% |
| Commodities (DBC) | 17.8% | 17.6% | 0.85 | 19.8% |
| Real Estate (VNQ) | 0.4% | 16.4% | -0.15 | 27.3% |
| Bitcoin (BTCUSD) | -23.7% | 44.2% | -0.49 | 31.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AEHR | |
|---|---|---|---|---|
| AEHR | 66.6% | 107.0% | 0.94 | - |
| Sector ETF (XLK) | 15.4% | 24.6% | 0.56 | 38.2% |
| Equity (SPY) | 11.8% | 17.0% | 0.54 | 36.8% |
| Gold (GLD) | 20.7% | 17.7% | 0.96 | 8.8% |
| Commodities (DBC) | 11.6% | 18.9% | 0.50 | 8.0% |
| Real Estate (VNQ) | 3.0% | 18.8% | 0.07 | 22.0% |
| Bitcoin (BTCUSD) | 4.0% | 56.6% | 0.29 | 17.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AEHR | |
|---|---|---|---|---|
| AEHR | 40.9% | 94.3% | 0.78 | - |
| Sector ETF (XLK) | 20.8% | 24.3% | 0.79 | 29.9% |
| Equity (SPY) | 14.0% | 17.9% | 0.67 | 28.4% |
| Gold (GLD) | 13.3% | 15.8% | 0.70 | 6.6% |
| Commodities (DBC) | 8.2% | 17.6% | 0.39 | 9.1% |
| Real Estate (VNQ) | 4.7% | 20.7% | 0.19 | 19.1% |
| Bitcoin (BTCUSD) | 66.4% | 66.8% | 1.06 | 8.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 1/8/2026 | 15.9% | 16.9% | 21.5% |
| 10/6/2025 | -17.4% | -19.4% | -21.6% |
| 7/8/2025 | -12.4% | -7.4% | 19.8% |
| 4/8/2025 | 29.2% | 26.0% | 24.3% |
| 1/13/2025 | -27.1% | -17.3% | -36.0% |
| 10/10/2024 | 20.3% | 11.0% | -9.9% |
| 7/9/2024 | 24.0% | 35.7% | 5.1% |
| 4/9/2024 | -2.1% | -1.6% | -4.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 10 | 9 | 10 |
| # Negative | 13 | 14 | 13 |
| Median Positive | 22.5% | 18.2% | 22.9% |
| Median Negative | -16.7% | -13.0% | -19.8% |
| Max Positive | 34.3% | 120.5% | 107.4% |
| Max Negative | -27.1% | -33.3% | -44.6% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 11/30/2025 | 01/12/2026 | 10-Q |
| 08/31/2025 | 10/08/2025 | 10-Q |
| 05/31/2025 | 07/28/2025 | 10-K |
| 02/28/2025 | 04/10/2025 | 10-Q |
| 11/30/2024 | 01/13/2025 | 10-Q |
| 08/31/2024 | 10/11/2024 | 10-Q |
| 05/31/2024 | 07/30/2024 | 10-K |
| 02/29/2024 | 04/10/2024 | 10-Q |
| 11/30/2023 | 01/12/2024 | 10-Q |
| 08/31/2023 | 10/12/2023 | 10-Q |
| 05/31/2023 | 08/28/2023 | 10-K |
| 02/28/2023 | 04/13/2023 | 10-Q |
| 11/30/2022 | 01/13/2023 | 10-Q |
| 08/31/2022 | 10/14/2022 | 10-Q |
| 05/31/2022 | 08/26/2022 | 10-K |
| 02/28/2022 | 04/13/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Slayen, Howard T | Director | Direct | Sell | 11052025 | 25.73 | 6,000 | 154,357 | 5,616,750 | Form |
| 2 | Danesh, Fariba | Director | Direct | Sell | 10102025 | 24.79 | 9,000 | 223,101 | 412,564 | Form |
| 3 | Oliphant, Laura | Director | Trust | Sell | 7252025 | 21.50 | 5,000 | 107,502 | 164,800 | Form |
| 4 | Posedel, Rhea J | Director | Direct | Sell | 7242025 | 19.83 | 18,000 | 356,972 | 1,411,290 | Form |
| 5 | Sporck, Alistair N | VP Contactor Business Unit | Direct | Sell | 7182025 | 14.13 | 3,000 | 42,390 | 435,317 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.